Table 1

Baseline characteristics of study population

OSA-negative (n=3 056 272)OSA-positive without treatment (n=21 764)OSA-positive with treatment (n=1478)
Age (years)61±1459±1157±10
Gender (male)2 840 692 (93)20 932 (96)1421 (96)
Outcomes
 Death671 645 (22)5996 (28)323 (22)
 Incident CHD event*68 268 (2)2537 (12)167 (12)
 Incident stroke event†50 333 (2)1601 (8)122 (9)
 New CKD290 037 (10)5486 (25)434 (29)
Race
 White2 153 744 (79)17 020 (80)1082 (74)
 African-American465 810 (17)3402 (16)333 (23)
 Hispanic63 138 (2)413 (2)16 (1)
 Other race57 445 (2)410 (2)25 (2)
Marital status
 Married1 606 708 (55)10 341 (50)735 (52)
 Single335 237 (11)2112 (10)166 (12)
 Divorced749 305 (26)6858 (33)435 (31)
 Widow229 756 (8)1538 (7)77 (5)
Other sociodemographic
 Income (USD)22 849 (11 522–36 929)20 327 (11 563–31 104)19 881 (11 805–30 893)
 Service connection1 154 717 (38)11 208 (51)778 (53)
 Baseline eGFR (mL/min./1.73 m2)84±1585±1587±16
 BMI (kg/m2)28.3±4.932.0±5.833.1±5.4
Comorbidities
 Hypertension1 763 151 (58)15 881 (73)1124 (76)
 Diabetes mellitus674 318 (22)8675 (40)644 (44)
 Cardiovascular disease‡333 638 (11)4105 (19)308 (21)
 Congestive heart failure121 312 (4)2691 (12)202 (14)
 Cerebrovascular disease186 119 (6)1910 (9)146 (10)
 Peripheral arterial disease164 507 (5)1959 (9)140 (9)
 Chronic lung disease524 645 (17)6592 (30)450 (30)
 Dementia27 440 (0.9)190 (0.9)12 (0.8)
 Rheumatological disease42 154 (1.4)370 (1.7)30 (2.0)
 Peptic ulcer disease56 591 (1.8)502 (2.3)34 (2.3)
 Liver disease37 795 (1.2)411 (1.9)22 (1.5)
 All malignancies327 064 (11)2296 (11)138 (9)
 AIDS/HIV19 958 (0.6)104 (0.5)5 (0.3)
 Depression249 958 (8)3325 (15)294 (20)
  • Dichotomous/dummy variables are presented as number of patients and percentage; continuous variables are presented as mean±SD or median (IQR).

  • *In cardiovascular disease-free (see below) patients at baseline.

  • †In stroke disease-free patients at baseline.

  • ‡Cardiovascular disease was defined as acute myocardial infraction, angina, coronary artery disease, previous coronary artery bypass grafting or percutaneous coronary intervention.

  • BMI, body mass index; CHD, coronary heart disease; CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; OSA, obstructive sleep apnoea.